Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.175
+0.145 (3.60%)
At close: Aug 13, 2025, 4:00 PM
4.180
+0.010 (0.24%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $530.52 million as of August 14, 2025. Its market cap has decreased by -36.56% in one year.
Market Cap
530.52M
Enterprise Value
292.18M
1-Year Change
-36.56%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $530.52M, a decrease of -76.53%. That is a compound annual growth rate of -30.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 530.52M | -36.54% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |